TRPV1 and early-onset autosomal dominant Alzheimer disease: confirmed that the intraperitoneal administration of a specific inhibitor of TRPV1 channels can lead to hippocampal astrocyte overactivation, prevent neuronal dysfunction and maintain structural synaptic integrity to ameliorate spatial working memory in Alzheimer's disease.34